innoscripta
innoscripta

pharmaceutical industry

R&D documentation for pharma innovation

Digital trials, new formulations, biotech breakthroughs. Structured evidence for every stage of development.

Image for - pharmaceutical industry
Allergopharma logoVygon GermanyAGFA HealthCare logoLeica Biosystems logoGOLLMANN logo

Every innovation deserves proper evidence

Drug Discovery & Formulation

  • Novel compound design and screening
  • Delivery system development
  • Dosage form engineering
  • Preclinical pharmacokinetics studies
Image for - Drug Discovery & Formulation

Clinical Research & Testing

  • Protocol design and validation
  • Trial software integration
  • Biomarker-based subgroup testing
  • Patient-reported data analysis
Image for - Clinical Research & Testing

Data & Compliance Systems

  • Automation of trial tracking logs
  • AI for adverse event classification
  • GxP-compliant system integration
  • Audit-ready report generation
Image for - Data & Compliance Systems

Recover part of your R&D spend

Find out exactly how much your company could recover, wherever you operate.

marquardt
Allergopharma GmbH & Co. KG
“The software from innoscripta helps us keep track of our projects. At any time, we can see where do we stand and which projects have been submitted. In addition, they bring highly valuable experience and can assess very well whether an application is likely to be successful (…). Working with innoscripta has not only helped us refinance our innovation costs but also optimize our internal processes, which is why we can recommend them without reservation.”
Christine Marquardt, Finance & ControllingAllergopharma GmbH & Co. KG
read story

See Clusterix in action

Book a walkthrough tailored to your R&D workflow.

innoscripta

The data layer for R&D, a continuous, verifiable record of the work your teams actually do, captured at source. Publicly listed, ISO 27001-certified, in 20+ countries.

innoscripta provides software solutions and supports companies in the funding, substantiation and documentation of their R&D activities. Its recommendations are based on the information provided and on the applicable regulations; decisions regarding claims remain the responsibility of the company.

Eligibility, rates and potential funding depend on the circumstances specific to each company and each project. Additional tax, legal or financial advice may be sought if required.

For further information, please refer to our information notice.



Copyright © 2026 - innoscripta SE

4 rue Jean Giono, Balma, France

+33 1 89 96 09 01

info@innoscripta.com

Research Allowance for Pharmaceutical Industry R&D